ScandiDos has recruited Gustaf Piehl as new CEO, taking office on September 7, 2020
CEO Görgen Nilsson "I am very proud to annonce that ScandiDos has received a strategic and high-profile order for two Delta4 Phantom+ MR from UMC Utrecht. We at ScandiDos view UMC Utrecht as a champion in the field of MRI-linac, because of its high expertise in the area as well as due its legacy as the university that together with Elekta developed the Elekta Unity. Therefore, the close...
CEO Görgen Nilsson "We are very happy and proud of the first order for a Delta4 Discover system in Italy. ScandiDos together with our Italian distributor DosimETrICA have a close and fruitful relationship with Ospedale Ivrea. Ospedale Ivrea has been working with our Delta4 Phantom+ since 2016 and have now decided to complement the current product with the Delta4 Discover system. The Delta4...
ScandiDos AB (publ) listed on First North, a world leading company in quality assurance of modern radiation therapy through advanced measurement and calculation methods. ScandiDos AB announces that the University Hospital in Uppsala, Sweden has placed an order for ScandiDos' newest product, the Delta4 Phantom+ MR. CEO Görgen Nilsson ScandiDos' latest product Delta4 Phantom+ MR has...
ScandiDos AB, a world-wide leader in quality assurance of modern radiation therapy through advanced measurement and calculation methods, and Radyalis LLC, a pioneer in advanced radiation therapy software technologies, have entered into a formal cooperation agreement to bring to market a leadership portfolio of next-generation quality assurance solutions. CEO Görgen Nilsson Through this...
ScandiDos AB (publ) listed on First North, is a world-leading company in quality assurance of modern radiation therapy through advanced measurement and calculation methods. ScandiDos AB announces the Delta4 Phantom+ and Delta4 HexaMotion are fully QA compatible with Accuray’s newest Synchrony technology. The Delta4 HexaMotion platform with 6 degrees of motion provides volumetric quality...
ScandiDos AB (publ) listed on First North, is a world-leading company in quality assurance of modern radiation therapy through advanced measurement and calculation methods. ScandiDos AB announces it has received FDA 510 (k) clearance on its newest product, the Delta4 Phantom+ MR, therefore the product can now be marketed and sold in the U.S. CEO Görgen Nilsson ScandiDos has received the...
ScandiDos AB (publ) listed on First North, is a world-leading company in quality assurance of modern radiation therapy through advanced measurement and calculation methods, has announced a new product within the Delta4 family of products. The Delta4 Phantom+ MR is adapted to be fully compatible with existing MR-linacs and is now released to a large part of the world market. CEO Görgen...
ScandiDos AB, the global leader in Quality Assurance and Dosimetry for modern radiation therapy, has received the first order for its Delta4 Discover system in Mexico from the Instituto Mexicano de Seguro Social (IMSS).
ScandiDos AB and Elekta have signed an Interoperability Agreement for the Delta4 Discover transmission detector
ScandiDos AB, the global leader in Quality Assurance and Dosimetry for modern radiation therapy, has received the first order for its Delta4 Discover system in the United States from The University Medical Center in Lubbock, Texas
The Delta4 Discover transmission detector, a state-of-the-art 4D in-vivo dosimetry system from ScandiDos, is now approved for use by Varian Medical Systems on TrueBeam® and Clinac® Systems